Theriva Biologics, Inc. Patent Application Trends in 2024

From WikiPatents

Jump to navigation Jump to search

Theriva Biologics, Inc. Patent Filing Activity

Theriva Biologics, Inc. patent applications in 2024

Top 10 Technology Areas

Error creating thumbnail: File missing

A61K38/50 (No explanation available)
- Count: 2 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K9/5078 (No explanation available)
- Count: 2 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K45/06 (No explanation available)
- Count: 2 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K9/5026 (No explanation available)
- Count: 2 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
C12Y305/02006 (No explanation available)
- Count: 2 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K9/1652 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K31/4164 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K31/424 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K31/43 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K31/7056 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)

Emerging Technology Areas

A61K31/546 (No explanation available)
- Count: 1 patents
- Example: 20240082370. SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION simplified abstract (Theriva Biologics, Inc.)
A61K9/5047 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K38/14 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K35/741 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K35/74 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K31/7056 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K31/43 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K31/424 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K31/4164 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)
A61K9/1652 (No explanation available)
- Count: 1 patents
- Example: 20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)

Top Inventors

Michael KALEKO of Rockville MD (US) (1 patent)
Sheila CONNELLY of Rockville MD (US) (1 patent)
Vincent John WACHER of Rockville MD (US) (1 patent)
Joseph Sliman of Rockville MD (US) (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors

Retrieved from "http://wikipatents.org/index.php?title=Theriva_Biologics,_Inc._Patent_Application_Trends_in_2024&oldid=110116"